Stewart-Feder (Finally) in Print

The appearance of Walter Stewart and Ned Feder's long-pending paper analyzing John Darsee's fraudulent scientific publications is extremely good news. It should be reassuring, both to scientists and to those who pay their bills. It shows that the system works. The venerable Nature, which published the paper in its January 15 issue, has once again served science well. The publication process was certainly protracted; various versions of the paper have been under consideration there and elsewhere

Written byTabitha Powledge
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The venerable Nature, which published the paper in its January 15 issue, has once again served science well. The publication process was certainly protracted; various versions of the paper have been under consideration there and elsewhere off and on since 1983. But drawn-out negotiations and repeated reviews resulted finally in an article presumably purged of potential grounds for libel suits. It was accompanied by a thoughtful two-page editorial and a commentary by Eugene Braunwald, one of Darsee's Harvard co-authors, whose attorney had been among the most importunate in the array of legal talent that came close to preventing publication altogether.

Darsee, you'll remember, was the Harvard postdoc who was caught making up data in 1981. Vast amounts of it, as it turned out, in scores of papers he published while at Harvard and at Emory University in Atlanta. Until its publication, the Stewart-Feder paper may well have been the best-known ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies